Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Pulmonary microcytoma].

A Santangelo

    Minerva Medica
    |February 28, 1987
    PubMed
    Summary
    This summary is machine-generated.

    This study on lung cancer treatment found no patients achieved disease-free survival at two years, even with radical surgery. Small cell lung cancer represented 9% of cases treated between 1980-1985.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Mediastinal teratoma as a cause of pleural effusion.

    Cirugia pediatrica : organo oficial de la Sociedad Espanola de Cirugia Pediatrica·2026
    Same author

    Minimally invasive treatment of splenic cysts in pediatric patients.

    Cirugia pediatrica : organo oficial de la Sociedad Espanola de Cirugia Pediatrica·2025
    Same author

    One-step endoscopic retrograde cholangiopancreatography and laparoscopic cholecystectomy: A safe strategy in pediatrics.

    Cirugia pediatrica : organo oficial de la Sociedad Espanola de Cirugia Pediatrica·2025
    Same author

    High-Statistics Measurement of the Cosmic-Ray Electron Spectrum with H.E.S.S.

    Physical review letters·2024
    Same author

    A machine learning-based analysis for the definition of an optimal renal biopsy for kidney cancer.

    Urologic oncology·2024
    Same author

    Hyperlysinemia, an ultrarare inborn error of metabolism: Review and update.

    Seizure·2024
    Same journal

    How to become a centenarian in four weeks?. Myths and limits of longevity recipes: a critical review.

    Minerva medica·2026
    Same journal

    Comparative efficacy and safety between intravenous recombinant human prourokinase and alteplase in acute ischemic stroke treatment: a meta-analysis of randomized controlled trials.

    Minerva medica·2026
    Same journal

    Efficacy and safety of oral tapentadol for cancer-related pain: an updated systematic review and meta-analysis.

    Minerva medica·2026
    Same journal

    Use of the neurostimulator in thyroidectomy procedures: comparison between vagal and recurrent laryngeal nerve stimulation.

    Minerva medica·2026
    Same journal

    Iron deficiency and risk of acute kidney injury after TAVI: a machine learning analysis.

    Minerva medica·2026
    Same journal

    Therapeutic adherence and health literacy: a perfect match in dyslipidemic patients.

    Minerva medica·2026
    See all related articles

    Area of Science:

    • Oncology
    • Thoracic Surgery
    • Cancer Research

    Context:

    • Retrospective analysis of 111 lung cancer patients treated between 1980-1985.
    • Small cell lung carcinoma comprised 9% of all histological types studied.
    • Treatment modalities included radical surgery where feasible, guided by TNM staging.

    Purpose:

    • To evaluate the outcomes of lung cancer treatment, specifically focusing on disease-free survival.
    • To analyze the impact of radical surgery on survival rates in different lung cancer histological types.
    • To assess the effectiveness of treatments administered during the 1980-1985 period.

    Summary:

    • No patients in the cohort achieved disease-free survival at the two-year mark post-treatment.
    • Radical surgery was employed for eligible cases, but did not result in long-term disease eradication.

    Related Experiment Videos

  • The findings highlight limited treatment efficacy for lung cancer during this period, particularly concerning small cell subtypes.

    • Impact:

    • This historical data underscores the urgent need for advancements in lung cancer therapies.
    • The results provide a benchmark for comparing the efficacy of contemporary lung cancer treatments.
    • Highlights the challenges in achieving durable remission for lung cancer patients, especially with advanced disease or specific histologies.